J Korean Med Sci.  2020 Oct;35(39):e358. 10.3346/jkms.2020.35.e358.

The First Case of an HIV Patient Diagnosed with COVID-19 in Korea

Affiliations
  • 1Division of Infectious Disease, Department of Medicine, Seongnam Citizens Medical Center, Seongnam, Korea
  • 2Department of Family Medicine, Seongnam Citizens Medical Center, Seongnam, Korea
  • 3Division of Infectious Disease, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Abstract

Although some comorbidities, such as diabetes mellitus, lung disease, and chronic kidney disease, are known as risk factors for poor clinical outcome in patients with coronavirus disease 2019 (COVID-19), it is unknown if human immunodeficiency virus (HIV) patients with COVID-19 would have poor prognosis than others. Rare cases of HIV patients with COVID-19 have been reported. As of May 25th, 2020, over 11,000 patients have been diagnosed with COVID-19 and over 13,000 are living with HIV in Korea. Here, we present the first HIV patient with COVID-19 in Korea. The 29-year-old Korean man had been taking Genvoya® regularly for seven years and HIV was well suppressed with CD4 counts of 555/mm 3 . He had mild symptoms of sore throat, dry cough, loss of taste and smell. He received hydroxychloroquine while Genvoya® was continued. Pneumonia diagnosed in chest computed tomography improved without oxygen supplementation. He was discharged on hospital day 31. HIV patients are considered as immunocompromised, but this case suggests that well controlled HIV patients have satisfactory prognosis following proper medical care.

Keyword

COVID-19; SARS-CoV-2; HIV

Figure

  • Fig. 1 Chest X-ray on hospital day 1 (day 8 of illness).

  • Fig. 2 Low dose chest computed tomography of the patient.(A, B) On HD 2 (day 9 of illness). (C) On HD 9 (day 16 of illness).HD = hospital day.

  • Fig. 3 Viral load kinetics of HIV with SARS-CoV2 patient.


Reference

1. Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020; 7(5):e314–e316. PMID: 32304642.
Article
2. Zhu F, Cao Y, Xu S, Zhou M. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. J Med Virol. 2020; 92(6):529–530. PMID: 32160316.
Article
3. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020; 92(11):2288–2290.
Article
4. Wu Q, Chen T, Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J Med Virol. Forthcoming 2020.
5. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020; 382(19):1787–1799. PMID: 32187464.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr